Does Alto Neuroscience, Inc. (ANRO) have what it takes to be a top stock pick for momentum investors? Let's find out.

At the edge of death, some people wake into sudden clarity. Terminal lucidity is one of the mind’s most baffling mysteries.

A new study reveals that how people think about and cope with chronic pain is more important than the pain itself in determining physical activity levels.

Researchers have discovered that problems with the brain’s waste-clearing system—the glymphatic system—may significantly ...

Brain.fm merges music and neuroscience to enhance focus, creativity, and mental health—Dr. Kevin Woods reveals how sound is ...

Your brain transforms thoughts into speech using an ancient blueprint: the sensorimotor control system. New research reveals ...

Neuroscience PhD grad Breanne Kearney studies how trauma impacts the brain and body. She earned the Governor General’s Gold Medal for scholastic achievement ...

The latest data from the US Department of Agriculture, correct as of October 23, reveals that almost 6.5 million birds have ...

Cognitive reappraisal or reframing is a powerful emotional regulation strategy, research shows. Stress, challenges and ...

Forget super shoes that make you run faster. Nike's newest footwear innovation might actually change the way you think.

Shares of Alto Neuroscience, Inc. (ANRO) have gained 162.9% over the past four weeks to close the last trading session at $10 ...

After a period of shareholder panic, the brand has unveiled four new innovations to prove that it’s still pioneering the ...